- The recommended dose is 1 tablet daily
- The tablets may be sucked, they should not be swallowed whole
How should Cadelius® be taken?
- The tablets should be taken preferably after meals
Patients on Osteoporosis treatments require adequate Calcium and Vitamin D¹
It can be difficult to achieve our vitamin D requirements through our diet2
Food remains the best source of calcium but supplements should be considered if dietary calcium intake is insufficient1
3-4 portions of any of the following can provide 1000mg of Calcium: 1,3
- A glass of fortified milk, or milk based drink (250mg of calcium)1,3
- A yogurt (100mg of calcium)1,3
- A portion of cheese (320mg of calcium)1,3
- A can of sardines (350mg of calcium)1,3
- A bowl of cereal or porridge with milk (155mg of calcium)1,3
- The Royal Osteoporosis Society. What are the Pharmacological Treatment Options? Available in the public domain: https://theros.org.uk/healthcare-professionals/courses-and-cpd/osteoporosis-resources-for-primary-care/initiation/, accessed July 2025
- International Osteoporosis Foundation , Calcium Calculator, https://www.osteoporosis.foundation/educational-hub/topic/calcium-calculator, accessed July 2025
- Consilient Health Ltd. Cadelius Summary of Product Characteristics available on medicines.ie
- NOGG 2017, Clinical Guidelines for the prevention and treatment of Osteoporosis. March 2017.
- The Royal Osteoporosis Society Guidelines : Vitamin D and Bone Health: A practical clinical guidelines for patient management. Version 2, December 2018.
- Consilient Health Ltd. Altavita D3 1,000 IU soft capsule Summary of Product Characteristics available on medicines.ie
- Consilient Health Ltd. Altavita D3 7,000 IU soft capsule Summary of Product Characteristics available on medicines.ie
- Consilient Health Ltd. Altavita D3 25,000 IU soft capsule Summary of Product Characteristics available on medicines.ie
- Consilient Health Ltd. Altavita D3 25,000 IU oral solution Summary of Product Characteristics available on medicines.ie
- Consilient Health Ltd. Altavita D3 50,000 IU Soft Capsules Summary of Product Characteristics available on medicines.ie
IE-CAD-434(1) October 2025
Adverse events should be reported. Reporting forms and information are available from HPRA Pharmacovigilance on the HPRA website www.hpra.ie.
Adverse events should also be reported to Consilient Health at drugsafety@consilienthealth.com or 012057766.
The information on this website is intended for Healthcare Professionals who practice in the Republic of Ireland only.